CDRE — Cadre Holdings, Inc.

Summary of Cadre Holdings, Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 Performance: Revenue and net income decreased compared to record Q4 2024, but full-year metrics showed significant growth.
• Adjusted EBITDA: Reached a record $111.7 million for 2025, marking a third consecutive year of growth.
• Gross Margins: Improved by 140 basis points year-over-year, with public safety products’ gross margins up 188 basis points.
• Backlog: Increased nearly 50% year-over-year, bolstered by new contracts, including a $50 million IDIQ contract with the U.S. military.

2. Strategic Updates and Business Highlights:

• Acquisitions: Completed the acquisition of TIER Tactical, enhancing capabilities in protective equipment and expanding market reach. Integration efforts are underway.
• Market Demand: Strong demand in public safety, defense, and nuclear safety sectors, with notable contract wins in advanced sensor technologies and blast mitigation seating.
• Operational Integration: Continued focus on integrating acquired businesses to leverage synergies and improve operational efficiency.
• Product Development: Successful introduction of new products, particularly in the consumer channel, with a 15% growth in the second half of 2025.

3. Forward Guidance and Outlook:

• 2026 Projections: Expected net sales between $736 million and $758 million, with adjusted EBITDA between $136 million and $141 million, reflecting a year-over-year growth of 22%-24%.
• Organic Growth: Anticipated organic growth of 3%-5% across public safety and nuclear segments, with a focus on maintaining pricing strategies amid material inflation.
• Q1 Expectations: Revenue expected to be similar to Q3 2025 levels, with margins around 39%, influenced by project timing and material constraints.

4. Bad News, Challenges, or Points of Concern:

• Nuclear Segment Challenges: A shift in focus from environmental cleanup to plutonium production has temporarily reduced demand for certain products, potentially impacting short-term revenue.
• Timing Issues: Delays in larger contract bookings have created uncertainty, although management expressed confidence that these are merely timing issues rather than losses.
• Government Shutdown Impact: Some revenue timing shifts were attributed to the government shutdown, affecting visibility and operational performance.
• Market Volatility: Potential geopolitical tensions and changes in government policy could pose risks to future contracts and operational stability.

5. Notable Q&A Insights:

• Visibility on Delayed Contracts: Management expressed high confidence that delayed contracts are not lost but rather postponed, with good visibility into the backlog.
• CapEx Plans: Increased capital expenditures for 2026 are primarily aimed at capacity expansion in the nuclear segment.
• TIER Tactical Contribution: Initial revenue expectations from TIER are set conservatively at approximately $100 million for the full year, with EBITDA margins projected around 20%.
• Blast Seat Contracts: Significant contracts awarded to Med-Eng for blast attenuation seats are expected to ramp up production and revenue contributions in 2026 and beyond.

This summary encapsulates the key points from the earnings call, highlighting both the positive developments and the challenges faced by Cadre Holdings, Inc. as they navigate their growth strategy and market dynamics.